Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue.
about
First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers.Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.Establishment of anti-mesothelioma monoclonal antibodiesSynthetic lethal interaction of combined CD26 and Bcl-xL inhibition is a powerful anticancer therapy against hepatocellular carcinoma.
P2860
Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Establishment of monoclonal an ...... ning of formalin-fixed tissue.
@en
Establishment of monoclonal an ...... ning of formalin-fixed tissue.
@nl
type
label
Establishment of monoclonal an ...... ning of formalin-fixed tissue.
@en
Establishment of monoclonal an ...... ning of formalin-fixed tissue.
@nl
prefLabel
Establishment of monoclonal an ...... ning of formalin-fixed tissue.
@en
Establishment of monoclonal an ...... ning of formalin-fixed tissue.
@nl
P2093
P2860
P356
P1433
P1476
Establishment of monoclonal an ...... ning of formalin-fixed tissue.
@en
P2093
Chikao Morimoto
Eriko Komiya
Hiroto Yamazaki
Kei Ohnuma
Nam H Dang
Ryo Hatano
Satoshi Iwata
Shuji Matsuoka
Taketo Yamada
Toshihiro Okamoto
P2860
P2888
P356
10.1186/1746-1596-9-30
P577
2014-02-06T00:00:00Z
P5875
P6179
1020211857